372 related articles for article (PubMed ID: 3537070)
1. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.
Chesebro JH; Adams PC; Fuster V
J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):41B-56B. PubMed ID: 3537070
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Whitlock RP; Sun JC; Fremes SE; Rubens FD; Teoh KH
Chest; 2012 Feb; 141(2 Suppl):e576S-e600S. PubMed ID: 22315272
[TBL] [Abstract][Full Text] [Related]
3. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
Trujillo JF; Hollenberg SM
FP Essent; 2017 Jun; 457():23-29. PubMed ID: 28671806
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Salem DN; Stein PD; Al-Ahmad A; Bussey HI; Horstkotte D; Miller N; Pauker SG
Chest; 2004 Sep; 126(3 Suppl):457S-482S. PubMed ID: 15383481
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Stein PD; Alpert JS; Dalen JE; Horstkotte D; Turpie AG
Chest; 1998 Nov; 114(5 Suppl):602S-610S. PubMed ID: 9822066
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Stein PD; Alpert JS; Bussey HI; Dalen JE; Turpie AG
Chest; 2001 Jan; 119(1 Suppl):220S-227S. PubMed ID: 11157651
[TBL] [Abstract][Full Text] [Related]
7. How to define valvular atrial fibrillation?
Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
[TBL] [Abstract][Full Text] [Related]
8. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic and bleeding complications of prosthetic heart valves.
Edmunds LH
Ann Thorac Surg; 1987 Oct; 44(4):430-45. PubMed ID: 3310938
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy for prosthetic valves: routine treatment and special considerations.
Al-Ahmad AM; Hartnett-Daudelin D; Salem DN
Curr Cardiol Rep; 2001 Jan; 3(1):85-9. PubMed ID: 11139804
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Little SH; Massel DR
Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in valvular heart disease preoperatively and postoperatively.
Bodnar AG; Hutter AM
Cardiovasc Clin; 1984; 14(3):247-64. PubMed ID: 6722854
[TBL] [Abstract][Full Text] [Related]
13. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of thrombosis in heart valve diseases].
Meyer BJ; Beer JH
Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
[TBL] [Abstract][Full Text] [Related]
15. Prosthetic Heart Valve Thrombosis.
Dangas GD; Weitz JI; Giustino G; Makkar R; Mehran R
J Am Coll Cardiol; 2016 Dec; 68(24):2670-2689. PubMed ID: 27978952
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic Management of Patients With Prosthetic Heart Valves.
Sanaani A; Yandrapalli S; Harburger JM
Cardiol Rev; 2018; 26(4):177-186. PubMed ID: 29608496
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in valvular heart disease.
Stein PD
Clin Geriatr Med; 2001 Feb; 17(1):163-72, viii. PubMed ID: 11270129
[TBL] [Abstract][Full Text] [Related]
20. Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillation.
Vink R; Van Den Brink RB; Levi M
Hematology; 2004 Feb; 9(1):1-9. PubMed ID: 14965863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
